Epperly Melissa B, Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

Epperly Melissa B, is Chief Financial Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 451,449 shares of ZNTL, which is worth approximately $1.58 Million. The most recent transaction as insider was on Nov 23, 2020, when has been sold 3,083 shares (Common Stock) at a price of $46.88 per share, resulting in proceeds of $144,531. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 451K

0% 3M change

16.45% 12M change

Total Value Held $1.58 Million

Epperly Melissa B, Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 23 2020	SELL Open market or private sale	$144,531 $46.88 p/Share	3,083 Reduced 1.04%	294,446 Common Stock
Apr 07 2020	BUY Open market or private purchase	$360,000 $18.0 p/Share	20,000 Added 6.3%	297,529 Common Stock

Also insider at

ROIV

Roivant Sciences Ltd. Healthcare

KNTE

Kinnate Biopharma Inc. Healthcare

NAUT

Nautilus Biotechnology, Inc. Healthcare

Director

EMB